So far, 12 severe cases of illness, including seizures, have been linked to the consumption of Diamond Shruumz brand mushroom-based chocolates and candies. The products are marketed as way to “microdose” (implying a drug-like effect), but also claim not to contain psychedelic substances.
The infant formula shortage of 2022 was precipitated by FDA’s delayed response to whistleblower complaints about contaminated product—a delay caused by the agency not having the necessary policies and procedures in place to address the issue at the time—according to a new report published by the U.S. DHHS’ Office of the Inspector General.
LSG Sky Chefs has selected Trustwell to develop its traceability recordkeeping system, which will bring the company into compliance with the U.S. Food and Drug Administration’s (FDA’s) Food Safety Modernization Act, Subpart 204 (FSMA 204).
An expert report commissioned by the U.S. Food and Drug Administration (FDA) weighed the nutritional benefits of seafood consumption against the health risk of dietary exposure to contaminants in seafood, with special consideration to childhood growth and development.
The U.S. Food and Drug Administration (FDA) has revealed preliminary findings from a multi-year environmental study of a specific growing region in the Southwest U.S., which sought to better understand the ecology of human pathogens in the environment.
Effective immediately, the Taiwan Food and Drug Authority (TFDA) has implemented new requirements for fishery products for human consumption imported into Taiwan. U.S. establishments that have an interest in exporting seafood products to Taiwan must contact U.S. FDA.
The U.S. Food and Drug Administration (FDA) recently announced that sufficient laboratory capacity has been reached for mycotoxins testing for food imports under the Laboratory Accreditation for Analyses of Foods (LAAF) program. Owners and consignees of imported food subject to the LAAF regulation must use a LAAF-accredited laboratory to conduct mycotoxins testing beginning December 1, 2024.
The U.S. Food and Drug Administration’s (FDA’s) proposed reorganization for a new, unified Human Foods Program (HFP) has been approved by the U.S. Department of Health and Human Services, and full implementation of the reorganization is set for October 1, 2024.
The National Advisory Committee on Microbiological Criteria for Foods (NACMCF) will hold a virtual public meeting on June 24 to provide updates on its charges from USDA and FDA regarding genomics and Cronobacter in powdered infant formula, respectively.